ACMR vs KD

ACMR's Piotroski F-Score of 2/9 indicates severe financial distress, with weak operational and profitability health. The Altman Z-Score is unavailable, but the company's negative earnings growth (-77.7% YoY) and declining EPS trend signal deteriorating fundamentals. Despite a strong gross margin (44.39%) and low debt/equity (0.15), the sharp drop in earnings and poor recent earnings surprises (average -20.81% over last 4 quarters) undermine confidence. The stock trades at a premium to its Graham Number ($26.23) and intrinsic value ($9.59), suggesting overvaluation relative to conservative metrics. Insider selling of $16.59M in the last 6 months further reinforces bearish sentiment.

Kyndryl presents a high-risk profile characterized by a stable Piotroski F-Score (5/9) but severe valuation and growth headwinds. The current price of $13.46 trades at a significant premium to both its Graham Number ($11.17) and Intrinsic Value ($7.35), suggesting the stock is overvalued despite low P/E and P/S multiples. Financial health is precarious with a high Debt/Equity ratio of 3.04 and a Current Ratio of 0.86, indicating potential liquidity constraints. This is further compounded by a collapse in earnings growth (-71.9% YoY) and a completely bearish technical trend (0/100).